Drug Profile
Research programme: calcineurin modulators - Galenea/Otsuka Pharmaceutical
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Galenea
- Class Small molecules
- Mechanism of Action Calcineurin modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Schizophrenia in USA
- 01 May 2012 Preclinical development is ongoing in the US
- 30 Mar 2010 Preclinical development is ongoing in USA